PHASE 1 SAFETY AND TOLERABILITY STUDY OF IMB-1018972, A NOVEL ORAL MODULATOR OF MYOCARDIAL SUBSTRATE UTILIZATION DESIGNED TO IMPROVE CARDIAC METABOLIC EFFICIENCY AND BIOENERGETICS
2021 ◽
Vol 77
(18)
◽
pp. 180
2009 ◽
Vol 19
(6)
◽
pp. 201-207
◽
1997 ◽
Vol 29
(4)
◽
pp. 1073-1086
◽
Keyword(s):
1988 ◽
Vol 82
(6)
◽
pp. 2017-2025
◽
1981 ◽
Vol 240
(4)
◽
pp. H659-H663
◽
2015 ◽
Vol 8
(2)
◽
pp. 292-301
◽
1986 ◽
Vol 94
(5)
◽
pp. 285-293
◽
1998 ◽
Vol 4
(2)
◽
pp. 127-129
◽